Matinas BioPharma Holdings Inc (MTNB) — Long-term Investment Intensity
Matinas BioPharma Holdings Inc (MTNB) has a Long-term Investment Intensity of 0.5% as of September 2016. Long-term investments of $54.84K represent 0.5% of total assets of $11.31 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Matinas BioPharma Holdings Inc shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Matinas BioPharma Holdings Inc Long-term Investment Intensity (2014–2015)
This chart shows how Matinas BioPharma Holdings Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2014 to 2015. As of September 2016, the intensity stands at 0.5%, reflecting long-term investments of $54.84K against total assets of $11.31 Million USD. Also explore MTNB current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Matinas BioPharma Holdings Inc (2014–2015)
The table below presents the year-by-year Long-term Investment Intensity for Matinas BioPharma Holdings Inc from 2014 to 2015, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MTNB company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2015 | 1.4% | $115.37K | $8.41 Million | ▼ -5.1 pp |
| 2014 | 6.4% | $216.32K | $3.36 Million | — |